期刊文献+

人健康和炎性牙槽骨成骨细胞COX-2、PGE2、OPG,RANKL的表达 被引量:8

Expressions and Reciprocity of COX-2,PGE2,OPG and RANKL in Healthy and Inflamed Human Osteoblasts
下载PDF
导出
摘要 目的:初步探讨COX-2、PGE2、OPG和RANKL在牙周炎发病机制中所起的作用及其相互关系。方法:采用组织块法对人健康和牙周炎性牙槽骨进行体外培养和传代,加入含100μg/LrhOPG的不含胎牛血清的DMEM2mL。严格按照ELISA试剂盒说明进行操作,获得各指标的检测数值。结果:牙周炎组RANKL、PGE2、COX-2的表达较健康组明显增高,OPG的表达较健康组明显降低。加入rhOPG后,牙周炎组RANKL、PGE2、COX-2的表达明显降低;OPG表达明显增加。健康组RANKL、PGE2、COX-2表达明显降低;OPG表达增加。结论:RANKL、PGE2、COX-2可促进牙周炎的发生、发展,而OPG对牙周炎的发生、发展可起抑制作用,同时表明人工重组OPG可能协同其内源性OPG来共同抑制RANKL、PGE2、COX-2的活性。 Objective:To investigate the expressions of the COX-2,PGE2,OPG and RANKL in healthy and inflamed humans osteoblasts,and to compare the levels of COX-2,PGE2,OPG and RANKL after adding the recombinant human osteoprotegerin(rhOPG)into the cell culture so as to clear whether the COX-2,PGE2,OPG and RANKL may play a role in periodontitis pathogenesis,and to provide the foundation of appling rhOPG in the treatment of periodontitis.Methods:The healthy and inflamed osteoblasts were grown from tissue explants and cells between the 5th and 6th passage in culture were used.Aliquots(2ml)of cells at a density of 1.5×106/ml were seeded into 12-well cell culture plates with 2ml media containing 10% FBS for 2days.After the media were removed,the wells were washed twice with PBS,2ml media(FBS-free)was replaced and incubated again for 24 hours.100ng/ml OPG media(FBS-free)were added into wells.The culture media were collected and stored similarly.According to the ELISA requirements,we carried out the operations strictly.Results:The expressions of RANKL,PGE2and COX-2in periodontitis groups were increased obviously than those in healthy group and the expression of OPG were reduced obviously in periodontitis group than those in healthy group.To add the rhOPG into the cell culture plates,the expressions of RANKL,PGE2,COX-2were reduced obviously and the expression of OPG were increased obviously in periodontitis groups.In healthy group,the expressions of RANKL and PGE2were reduced obviously.The expression of COX-2were reduced(P0.05).The expression of OPG were increased.Conclusion:The results showed that the RANKL,OPG,PGE2and COX-2were related closely with pathogenesis of periodontitis.The action of rhOPG together with the synergistic action of the endogenous OPG may reduce the expressions of RANKL,PGE2and COX-2in osteoblasts of periodontitis.
出处 《口腔医学研究》 CAS CSCD 北大核心 2010年第4期529-533,共5页 Journal of Oral Science Research
关键词 人牙槽骨成骨细胞 核因子κB受体活化子 骨保护素 前列腺素E2 环氧酶-2 Osteoblast Osteoprotegerin Receptor activator of nuclear factor-κB Ligand cyclooxygenase-2 Prostaglandin E2
  • 相关文献

参考文献14

  • 1Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differ entiation factor is a ligand for osteoprotegerin/ostcoelast in hibitory factor and isidentical to TRANCE/ RANKL [J]. PNAS USA, 2005, 95(7) : 3597-3602.
  • 2Lorenz C, Hofbauer, Armin E, et al. Role of receptor acti vator of NFkB ligand factor and osteoprotegerin in bonebiology [J]. JMM, 2001, 79(5-6): 243-253.
  • 3Mizuno A, Amizuka N, Irie K, et al. Severe osteoporosis in miee lacking osteoelastogenesis inhibitory factor/osteoprotegerin[J]. Biochem Res, 1998, 247(3): 610-5.
  • 4司徒镇强,军正.细胞培养[M].世界图书出版社西安公司出版发行,1964,78.
  • 5Mori G, Brunetti G, Colucci S, et al. Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL[J].JBRH, 2007, 21(3-4) : 105 -14.
  • 6乔文静 钟雯忆 钱毅.牙周炎性牙槽骨成骨细胞的培养和鉴定初探.口腔医学研究,2009,25(3):7-9.
  • 7Noguchi K, Yanai M, Shitashige M, et al. Cyclooxygenase- 2-dependent prostaglandin production by peripheral blood rnonocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria [J]. J Periodontol, 2000, 71 (10) : 1575-82.
  • 8刘琪,David Haynes,Mark Bartold.慢性牙周炎中核因子κB受体活化子、护骨素和肿瘤坏死因子-α的蛋白表达[J].口腔医学,2004,24(6):347-349. 被引量:16
  • 9Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF -kB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis [J].J Periodont Res, 2003, 38 : 380-387.
  • 10Mogi M, Otogoto J, Ota N, et al. Differential expression of RANKL and osteoprotegerin in gingivaI erevieular fluid of patients with periodontitis [J].J Dent Res, 2004, 83 (2) : 166-169.

二级参考文献12

  • 1Takayanagi H, Iizuka H, Juji T, et al. Involvement of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis[ J ]. Arthritis Rheum,2000,43(2) :259 - 269.
  • 2Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclast inhibitory factor and is identical to TRANCE/RANKL[J]. Proc Natl Acad Sci USA, 1998,95(7) :3597 - 3602.
  • 3Quinn JMW, Horwood NJ, Elliott J, et al. Fibroblastic stromal cells express receptor activator of NF-kappa Bligand and support osteoelast differentiation[ J] .J Bone Miner Res,2000,15(8):1459- 1466.
  • 4LorenzC, Hotbauer, ArminE, etal. Role of receptor activator of NF kB ligand factor and osteoprotegerin in bone biology [ J ]. J Mol Med,2001,79(5 - 6) :243 - 253.
  • 5Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation[ J ]. Cell,1998,93(2): 165 - 176.
  • 6Yasuda H, Shima N, Nakagawa N, et al. Ideatity of osteoclastogenesis inhibitory factor(OCIF) and osteoprotegerin(OPG): a mechanism by which OPG/OCIF inhibits osteoclasttogenesis in vitro[J]. Endocrinology, 1998,139(3): 1329 - 1337.
  • 7Al Haj A, Lafont A, Durand E, et al. Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts [J]. Matrix Biol,2003,22(3) :251 - 258.
  • 8Hofbauer LC, Lacey DL, Dunstan CR, et al. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells[ J ]. Bone, 1999, 25 ( 3 ):255 - 259.
  • 9Kraan MC, Haringman JJ, Ahern MJ, et al. Quantification of the cell infiltrate in synovial tissue by digital image analysis[J]. Rheumatology,2000,39( 1 ) :43 - 49.
  • 10Tak PP, Van Der, Lubbe PA, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis[ J]. Arthritis Rheum, 1995,38(10): 1457 - 1465.

共引文献15

同被引文献153

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部